MFAP3L Activators

Common MFAP3L Activators include, but are not limited to Erlotinib, Free Base CAS 183321-74-6, Gefitinib CAS 184475-35-2, Lapatinib CAS 231277-92-2, U-0126 CAS 109511-58-2 and PD 98059 CAS 167869-21-8.

MFAP3L, or Microfibril Associated Protein 3 Like, is a significant player in cellular signaling pathways, especially those that concern cell motility and metastasis. This protein functions as a dual-specificity kinase, enabling the phosphorylation of both tyrosine and threonine on its target proteins. A unique feature of MFAP3L's activation is its dependency on the EGF receptor (EGFR) for phosphorylation. When the EGFR initiates its action, it sets off a kinase cascade, culminating in the promotion of cell motility. This mechanism implies that MFAP3L operates within a broader network of cellular signals and has the potential to influence cell movement substantially. Such functions are paramount when considering the dynamic nature of cells, especially in scenarios of tissue repair, immune response, and, unfortunately, in pathological processes like tumor metastasis.

Delving deeper into the pathological implications, MFAP3L has shown involvement in the invasion and metastasis of colorectal cancer cells. This involvement operates through the ERK2 pathway. A significant observation in studies has been the correlation between the abundance of MFAP3L and the occurrence of distant and hepatic metastasis in colorectal cancer. One of the potential explanations for this correlation is the activation of the nuclear ERK pathway, which results from MFAP3L phosphorylation. This connection further emphasizes the protein's role in metastatic processes. Moreover, MFAP3L might play a role in the nuclear signaling of EGFR and MAPK1/ERK2, hinting at its multifaceted involvement in cellular processes. Given the protein's functions and its association with cancer metastasis, any potential activators of MFAP3L would be of immense interest for studying the regulation of these cellular pathways.